Comparative effects of rosuvastatin and atorvastatin on glucose metabolism and adipokine levels in non-diabetic patients with dyslipidaemia: a prospective randomised open-label study

Atorvastatin does not affect insulin sensitivity and the adiponectin or leptin levels in hyperlipidemic Type 2 diabetes

(2014) C. H. Chu et al.   JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

Preventing Type 2 Diabetes Mellitus: Room for Residual Risk Reduction After Lifestyle Changes?

(2011) V. G. Athyros et al.   CURRENT PHARMACEUTICAL DESIGN

Effect of homeostasis model assessment computational method on the definition and associations of insulin resistance

(2010) Olusegun A. Mojiminiyi et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Comparison Of The Effects Of Atorvastatin And Simvastatin In Women With Polycystic Ovary Syndrome: A Prospective, Randomized Study

(2010) C. Kaya et al.   EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

Lipid-lowering agents and new onset diabetes mellitus

(2010) Vasilios G Athyros et al.   EXPERT OPINION ON PHARMACOTHERAPY

Effects of Atorvastatin 20 mg, Rosuvastatin 10 mg, and Atorvastatin/Ezetimibe 5 mg/5 mg on Lipoproteins and Glucose Metabolism

(2010) Ae-Young Her et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS

Atorvastatin Causes Insulin Resistance and Increases Ambient Glycemia in Hypercholesterolemic Patients

(2010) Kwang Kon Koh et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

(2010) Naveed Sattar et al.   LANCET

Comparative Study of Low Doses of Rosuvastatin and Atorvastatin on Lipid and Glycemic Control in Patients with Metabolic Syndrome and Hypercholesterolemia

(2010) Jong-Seon Park et al.   KOREAN JOURNAL OF INTERNAL MEDICINE

Early vascular and metabolic effects of rosuvastatin compared with simvastatin in patients with type 2 diabetes

(2009) Alfonso Bellia et al.   ATHEROSCLEROSIS

Should Adipokines be Considered in the Choice of the Treatment of Obesity-Related Health Problems?

(2009) Vasilios Athyros et al.   CURRENT DRUG TARGETS

Nonalcoholic Fatty Liver Disease: The Pathogenetic Roles of Insulin Resistance and Adipocytokines

(2009) Stergios Polyzos et al.   CURRENT MOLECULAR MEDICINE

Rosuvastatin treatment is associated with an increase in insulin resistance in hyperlipidaemic patients with impaired fasting glucose

(2009) M. S. Kostapanos et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Serum adiponectin is decreased in patients with familial combined hyperlipidemia and normolipaemic relatives and is influenced by lipid-lowering treatment

(2009) M. Arca et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Differential metabolic effects of pravastatin and simvastatin in hypercholesterolemic patients

(2008) Kwang Kon Koh et al.   ATHEROSCLEROSIS

EFFECTS OF ATORVASTATIN AND PRAVASTATIN ON GLUCOSE TOLERANCE, ADIPOKINE LEVELS AND INFLAMMATORY MARKERS IN HYPERCHOLESTEROLAEMIC PATIENTS

(2008) Hitoshi Ando et al.   CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY

HOMA or QUICKI: Is it useful to test the reproducibility of formulas?

(2008) B. Antuna-Puente et al.   DIABETES & METABOLISM

Efficacy of atorvastatin for the treatment of nonalcoholic steatohepatitis with dyslipidemia

(2008) Hideyuki Hyogo et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

(2008) Paul M Ridker et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effect of Atorvastatin Versus Rosuvastatin on Levels of Serum Lipids, Inflammatory Markers and Adiponectin in Patients with Hypercholesterolemia

(2008) Hai-yan Qu et al.   PHARMACEUTICAL RESEARCH